2022³âµµ ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ Á¦12Â÷ ½ÉÆ÷Áö¾ö (¿ÀÇÁ¶óÀÎ) : 2022-02-18±³À°ÀÏÀÚ : 2022-02-18
±³À°Àå¼Ò : ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ °è¸²È¦
±³À°ÁÖÁ¦ :
2022³âµµ ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ Á¦12Â÷ ½ÉÆ÷Áö¾ö (¿ÀÇÁ¶óÀÎ)ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ
´ã´çÀÚ : ÀÌÇѳª
¿¬¶ôó : 02-401-1570
À̸ÞÀÏ :
kscm.office@gmail.com ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаúºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í Á¤È¸¿ø: 7¸¸¿ø ÁØȸ¿ø: 4¸¸¿ø ´Üüȸ¿ø: 10¸¸¿ø ¸í¿¹È¸¿ø: 0¿ø(¾øÀ½) ºñȸ¿ø: 25¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-18 °è¸²È¦ 09:00~09:30 Mycobacterial infection ¹ÚÁ¤¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02-18 °è¸²È¦ 09:30~10:00 Influenza and other respiratory virus ±è¿µÁø(°æÈñÀÇ´ë)
±³À°½Ã°£ 02-18 °è¸²È¦ 10:00~10:30 Epidemiology of pathogenic bacteria Á¤Çý¼±(ÀÌÈÀÇ´ë)
ÈÞ½Ä 02-18 °è¸²È¦ 10:30~11:00 ÈÞ½Ä ()
±³À°½Ã°£ 02-18 °è¸²È¦ 11:00~11:30 Trend of AMR during the COVID-19 pandemic in Japan Keigo Shibayama(Nagoya University)
±³À°½Ã°£ 02-18 °è¸²È¦ 11:30~12:00 Trend of AMR during the COVID-19 pandemic in Korea Á¤¼¼¸®(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 02-18 °è¸²È¦ 12:00~13:00 Current status of SARS-CoV-2 variant ÀÌÁö¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02-18 °è¸²È¦ 13:00~13:30 Laboratory tests for antimicrobial resistance: old and new ÇãÈñÀç(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02-18 °è¸²È¦ 13:30~14:00 Antifungal resistance status and mechanisms of fungal infection in Korea ¿øÀºÁ¤(Àü³²ÀÇ´ë)
±³À°½Ã°£ 02-18 °è¸²È¦ 14:00~14:50 EUCAST: an internationally accepted system for antimicrobial susceptibility testing Gunnar Kahlmeter(EUCAST Development Laboratory)
ÈÞ½Ä 02-18 °è¸²È¦ 14:50~15:10 ÈÞ½Ä ()
±³À°½Ã°£ 02-18 °è¸²È¦ 15:10~15:40 Changes in antibiotic use in COVID-19 pandemic À¯¼®Çö(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 02-18 °è¸²È¦ 15:40~16:10 Laboratory response to community influx of Covid-19 ¹Ú¼º±Õ(°è¸íÀÇ´ë)
±³À°½Ã°£ 02-18 °è¸²È¦ 16:10~16:40 Healthcare-associated infection control in Covid-19 era ±è¼ºÇÑ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 02-18 °è¸²È¦ 16:40~17:10 Hand hygiene in COVID-19 era ÃÖÁ¤È(°Ç±¹´ëÇб³º´¿ø)
Åä·Ð 02-18 °è¸²È¦ 17:10~17:30 Åä·Ð ´Ù°»ç(´Ù¼Ò¼Ó)